SecBot SecBot
PRESS-RELEASE ·Filed Jul 13, 2026

EVO

Evotec SE
BEARISH
Impact 8/10
Horizondays Processed3mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The historic severity of this EPS miss — even as preliminary unaudited data — warrants immediate scrutiny. If the miss reflects a one-time impairment or restructuring charge, the selloff may be exaggerated; if it signals a structural revenue decline or margin collapse, further downside risk exists. Await the full filing for breakdown.

DirectionBearish
Confidencelow
Horizondays
Final — all horizons settled through T+60d
EVO ▼ -32.92% at T+60d
SHORT call ✓ call won +32.92% · α vs SPY +36.92% · entry $2.43 → $1.63
Entry = T+0 close
Jul 13, 2026
via day close
T+1d
-11.93%
call +11.93% · α +12.29%
$2.14
settled 4mo ago
T+5d
-19.34%
call +19.34% · α +18.56%
$1.96
settled 3mo ago
T+20d
-14.40%
call +14.40% · α +17.59%
$2.08
settled 3mo ago
T+60d
-32.92%
call +32.92% · α +36.92%
$1.63
settled 21d ago

Price Chart

Loading chart...

Executive Summary

Evotec SE reported preliminary Q2 2026 results with EPS of -€0.69, a massive miss vs the €0.09 consensus (-911.8% surprise), and revenue of €175.4M (widely below consensus, though precise consensus revenue estimate was not disclosed). The severity of the EPS miss — driven by undisclosed operational setbacks or charges — signals material deterioration versus street expectations.

Key Financial Metrics

EPS
−$0.69
est $0.09 · -911.8%
Revenue
$175.4M
Rating
strong miss

Key Facts

  • EPS of -€0.69 missed consensus estimate of €0.09 by 911.8%
  • Revenue came in at €175.4M vs undisclosed consensus
  • Preliminary unaudited results for Q2 2026 released July 13, 2026
  • Severe earnings miss indicates possible operational deterioration

Financial Impact

EPS miss of -€0.69 vs €0.09 consensus represents approximately -911.8% surprise

epsrevenue

Risk Factors

  • Potential further downgrades if full filing reveals worsening fundamentals
  • Preliminary nature suggests possible further adjustments in final report
  • Market cap of only $247M leaves limited buffer against negative surprises

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
58% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302824155
9 reports for EVO
Performance horizon
100% Hit rate @ T+1 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+20▲ +14.36%Aug 13, 2026
Filters
Rows
Reports for EVO — sortable, filterable
TypeNow
Oct 15, 2026
11d ago
6-K
BEARISH ★ 6/10
$1.42 $1.38▲ +2.82%▲ +1.71%$1.52 (−7.04%)
Oct 14, 2026
12d ago
SC 13D/A
BEARISH ★ 7/10
$1.42 $1.38▲ +2.82%▲ +1.71%$1.52 (−7.04%)
Oct 14, 2026
12d ago
6-K
BEARISH ★ 5/10
$1.43 $1.42▲ +0.35%▲ +0.64%$1.52 (−6.67%)
Sep 29, 2026
27d ago
6-K
NEUTRAL ★ 3/10
$1.64 $1.71▲ +4.27%▲ +4.47%$1.52 (−7.32%)
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$1.81 $1.77▼ −2.21%▼ −1.61%$1.52 (−16.02%)
Aug 13, 2026
10w ago
6-K
BEARISH ★ 7/10
$2.02 $1.96▲ +2.97%▲ +2.77%$1.52 (+24.75%)
Jul 13, 2026
15w ago
Press Release
BEARISH ★ 8/10
$2.43 $2.14▲ +11.93%▲ +12.29%$1.52 (+37.45%)
Jun 30, 2026
16w ago
6-K
BULLISH ★ 5/10
$2.80 $2.85▲ +1.79%▲ +1.92%$1.52 (−45.71%)
Jun 17, 2026
18w ago
6-K
NEUTRAL ★ 3/10
$2.61 $2.56▼ −1.92%▼ −2.70%$1.52 (−41.76%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 8h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 13, 2026